DXCM vs. VRSK
DXCM (DexCom, Inc.) and VRSK (Verisk Analytics, Inc.) are both stocks. DXCM operates in Diagnostics & Research (Healthcare), while VRSK operates in Consulting Services (Industrials). Over the past 10 years, DXCM returned 13.56%/yr vs 8.59%/yr for VRSK. At a 0.32 correlation, their price movements are largely independent.
Performance
DXCM vs. VRSK - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DXCM achieves a 4.07% return, which is significantly higher than VRSK's -24.06% return. Over the past 10 years, DXCM has outperformed VRSK with an annualized return of 13.56%, while VRSK has yielded a comparatively lower 8.59% annualized return.
DXCM
- 1D
- -4.69%
- 1M
- -4.20%
- YTD
- 4.07%
- 6M
- 2.43%
- 1Y
- -13.66%
- 3Y*
- -18.32%
- 5Y*
- -8.54%
- 10Y*
- 13.56%
VRSK
- 1D
- -2.77%
- 1M
- -0.97%
- YTD
- -24.06%
- 6M
- -22.94%
- 1Y
- -44.28%
- 3Y*
- -8.38%
- 5Y*
- 0.36%
- 10Y*
- 8.59%
DXCM vs. VRSK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
DXCM DexCom, Inc. | 4.07% | -14.66% | -37.33% | 9.58% | -15.64% | 45.23% | 69.02% | 82.59% | 108.75% | -3.87% |
VRSK Verisk Analytics, Inc. | -24.06% | -18.23% | 16.00% | 36.24% | -22.33% | 10.85% | 39.89% | 37.92% | 13.58% | 18.27% |
Correlation
The correlation between DXCM and VRSK is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.14 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.29 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.32 |
Correlation (All Time) Calculated using the full available price history since Oct 7, 2009 | 0.32 |
The correlation between DXCM and VRSK shifts across timeframes, from 0.12 (3 years) to 0.32 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
DXCM:
$27.19B
VRSK:
$22.85B
DXCM:
$2.31
VRSK:
$6.56
DXCM:
29.85
VRSK:
25.74
DXCM:
0.71
VRSK:
1.40
DXCM:
5.76
VRSK:
7.55
DXCM:
$4.82B
VRSK:
$3.10B
DXCM:
$2.96B
VRSK:
$2.09B
DXCM:
$1.37B
VRSK:
$1.46B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DXCM vs. VRSK — Risk / Return Rank
DXCM
VRSK
DXCM vs. VRSK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for DexCom, Inc. (DXCM) and Verisk Analytics, Inc. (VRSK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DXCM | VRSK | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.07 | ||
| Sortino ratioReturn per unit of downside risk | +1.89 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 0.74 | +0.24 |
| Calmar ratioReturn relative to maximum drawdown | -0.35 | -0.90 | +0.54 |
| Martin ratioReturn relative to average drawdown | -0.60 | -1.42 | +0.83 |
Loading charts...
Drawdowns
DXCM vs. VRSK - Drawdown Comparison
The maximum DXCM drawdown since its inception was -94.61%, which is greater than VRSK's maximum drawdown of -50.81%. Use the drawdown chart below to compare losses from any high point for DXCM and VRSK.
Loading charts...
Drawdown Indicators
| DXCM | VRSK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.61% | -50.81% | -43.80% |
Max Drawdown (1Y)Largest decline over 1 year | -38.75% | -49.57% | +10.82% |
Max Drawdown (3Y)Largest decline over 3 years | -60.95% | -50.81% | -10.14% |
Max Drawdown (5Y)Largest decline over 5 years | -66.32% | -50.81% | -15.51% |
Max Drawdown (10Y)Largest decline over 10 years | -66.32% | -50.81% | -15.51% |
Current DrawdownCurrent decline from peak | -57.58% | -46.86% | -10.72% |
Average DrawdownAverage peak-to-trough decline | -36.04% | -7.29% | -28.75% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 22.94% | 31.11% | -8.17% |
Volatility
DXCM vs. VRSK - Volatility Comparison
DexCom, Inc. (DXCM) has a higher volatility of 10.88% compared to Verisk Analytics, Inc. (VRSK) at 8.04%. This indicates that DXCM's price experiences larger fluctuations and is considered to be riskier than VRSK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DXCM | VRSK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.88% | 8.04% | +2.84% |
Volatility (6M)Calculated over the trailing 6-month period | 25.88% | 25.65% | +0.23% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.18% | 31.80% | +9.38% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 47.07% | 24.35% | +22.72% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 48.45% | 24.04% | +24.41% |
Dividends
DXCM vs. VRSK - Dividend Comparison
DXCM has not paid dividends to shareholders, while VRSK's dividend yield for the trailing twelve months is around 1.12%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
DXCM DexCom, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VRSK Verisk Analytics, Inc. | 1.12% | 0.80% | 0.57% | 0.57% | 0.70% | 0.51% | 0.52% | 0.67% |
Financials
DXCM vs. VRSK - Financials Comparison
This section allows you to compare key financial metrics between DexCom, Inc. and Verisk Analytics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
DXCM vs. VRSK - Profitability Comparison
DXCM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, DexCom, Inc. reported a gross profit of 750.30M and revenue of 1.19B. Therefore, the gross margin over that period was 63.0%.
VRSK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Verisk Analytics, Inc. reported a gross profit of 546.00M and revenue of 782.60M. Therefore, the gross margin over that period was 69.8%.
DXCM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, DexCom, Inc. reported an operating income of 255.30M and revenue of 1.19B, resulting in an operating margin of 21.4%.
VRSK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Verisk Analytics, Inc. reported an operating income of 352.20M and revenue of 782.60M, resulting in an operating margin of 45.0%.
DXCM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, DexCom, Inc. reported a net income of 199.50M and revenue of 1.19B, resulting in a net margin of 16.7%.
VRSK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Verisk Analytics, Inc. reported a net income of 234.20M and revenue of 782.60M, resulting in a net margin of 29.9%.
Frequently Asked Questions
DXCM and VRSK have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DXCM has higher volatility (10.88%) compared to VRSK (8.04%). In terms of maximum drawdown, DXCM dropped -94.61% vs VRSK's -50.81%.
DXCM currently has the higher Sharpe Ratio (-0.33 vs -1.40), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DXCM and VRSK
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer